STOCKSSTAR retweeted
Trump says the Iran war is “over,” and within a week, Nvdia, Microsoft and the American flight system are taken down and the head of Mossad comes to visit him.
That’s not a coincidence.
Ousted Nvidia chief executive officer Jensen Huang is discussing a possible comeback to the company just days after the board of directors pushed him out, the Financial Times reported bloomberg.com/news/articles/…
STOCKSSTAR retweeted
Top 10 Safest Countries
1. 🇸🇬 Singapore: 98%
2. 🇹🇯 Tajikistan: 95%
3. 🇨🇳 China: 94%
4. 🇴🇲 Oman: 94%
5. 🇸🇦 Saudi Arabia: 93%
6. 🇭🇰 Hong Kong SAR: 91%
7. 🇰🇼 Kuwait: 91%
8. 🇳🇴 Norway: 91%
9. 🇧🇭 Bahrain: 90%
10. 🇦🇪 UAE: 90%
Source: Gallup’s Global Safety Report 2025.
STOCKSSTAR retweeted
जम्मू कश्मीर के किश्तवाड़ में आतंकी हमले में शहीद SPO जवानों के शव बिना ताबूत और डंपर में रखकर घर पहुँचाए गए !
गाँव वालों ने खुद स्ट्रेचर और सफेद कपड़े का इंतजाम किया
STOCKSSTAR retweeted
Surviving a first stroke leaves patients facing a high risk of a second attack, even while taking standard daily medications like aspirin. On November 9, 2026, the U.S. Food and Drug Administration approved Sunharbo, known scientifically as asundexian, a first-of-its-kind daily tablet that lowers the relative risk of a repeat clot-related stroke by 26 percent when added to standard antiplatelet therapy.
For decades, stronger blood thinners carried a dangerous catch because stopping brain clots also blocked normal wound healing, triggering severe internal bleeding. Asundexian breaks that trade-off by selectively targeting factor XIa, a single clotting protein that fuels dangerous blockages inside blood vessels while playing only a minor role in sealing everyday cuts. By quieting that protein, the pill protects the brain without disabling the body's natural bleeding defenses.
In the global OCEANIC-STROKE clinical trial of 12,327 stroke and mini-stroke survivors, adding asundexian reduced repeat ischemic strokes from 8.4 percent to 6.2 percent and cut disabling or fatal strokes by 31 percent, with no overall surge in major bleeding. Doctors note that the medication is approved specifically for non-cardioembolic strokes and requires careful medical supervision, particularly for adults over age 75.
Primary Source: Sharma M, et al. Asundexian for Secondary Stroke Prevention. New England Journal of Medicine. 2026;394:1467-1479. DOI: 10.1056/NEJMoa2513880
Secondary Source: U.S. Food and Drug Administration (FDA). "FDA Approves First Factor XIa Inhibitor to Help Prevent Stroke in Certain Adults at High Risk." FDA Press Announcements, November 9, 2026.
STOCKSSTAR retweeted
Fixed this headline for you, @Reuters.
STOCKSSTAR retweeted
NEW: Trump bought up to $5 million in Nvidia stock a day before lifting limits on its China sales.
In December, he bought up to $25 million more as he approved Nvidia chip sales to China.
STOCKSSTAR retweeted
Two SPOs martyred in Kishtwar.
Their bodies were returned in a dump truck -no coffins, no stretchers, and the burial cloth was arranged by local villagers.
Millions of dollars are spent on foreign lobbying for Modi, yet martyrs get a truck bed.
Ask where the money goes.
STOCKSSTAR retweeted
The same British writer, Lance Price, who had never heard of Narendra Modi, was compensated to compose a book on Modi in 2014. And this is not stated by any opposition leader; it is stated by the writer himself. Lance Price, the author of The Modi Effect, received an undisclosed sum of money. The question is straightforward: why was it necessary to spend money to create Modi's image if the Modi Wave was so real? #narendramodi #modikajhooth #bjp #india




































